Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV

被引：6
|
作者：
Wilder-Smith, A. [1 ,2 ]
机构：
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 07期
关键词：
CYD-TDV; Dengue; Safety follow-up; Tetravalent dengue vaccine; Vaccine;
D O I：
10.1016/j.cmi.2018.03.024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：680 / 681
页数：2
相关论文
共 45 条
  • [21] PREDICTIONS OF DEPRESSION AND SEXUAL STIGMA FOR MOTIVATION TO VACCINATE AGAINST COVID-19 AMONG YOUNG ADULT LESBIAN, GAY AND BISEXUAL INDIVIDUALS: A FOUR-YEAR FOLLOW-UP STUDY
    Yen, Cheng-Fang
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i128 - i129
  • [22] Follow-up of Gambian children recruited to a Pilot safety and immunogenicity study of the malaria vaccine SPf66
    Bojang, KA
    Obaro, SK
    Leach, A
    D'Alessandro, U
    Bennett, S
    Metzger, W
    Ballou, WR
    Targett, GAT
    Greenwood, BM
    PARASITE IMMUNOLOGY, 1997, 19 (12) : 579 - 581
  • [23] Response to anti-HBV vaccine and 10-year follow-up of antibody levels in healthcare workers
    La Fauci, V.
    Riso, R.
    Facciola, A.
    Ceccio, C.
    Lo Giudice, D.
    Calimeri, S.
    Squeri, R.
    PUBLIC HEALTH, 2016, 139 : 198 - 202
  • [24] Long-term Immunogenicity and Safety of the AS04-adjuvanted Human Papillomavirus-16/18 Vaccine in Four- to Six-year-old Girls Three-year Follow-up of a Randomized Phase III Trial
    Lin, Lan
    Macias Parra, Mercedes
    Sierra, Victor Y.
    Salas Cespedes, Albino
    Granados, Maria Angelica
    Luque, Adriana
    Karkada, Naveen
    Castrejon Alba, Maria Mercedes
    Romano-Mazzotti, Luis
    Borys, Dorota
    Struyf, Frank
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2019, 38 (10) : 1061 - 1067
  • [25] Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
    Lanata, Claudio F.
    Andrade, Teresa
    Gil, Ana I.
    Terrones, Cynthia
    Valladolid, Omar
    Zambrano, Betzana
    Saville, Melanie
    Crevat, Denis
    VACCINE, 2012, 30 (41) : 5935 - 5941
  • [26] Safety and efficacy of dendritic cell vaccine for COVID-19 prevention after 1-Year follow-up: phase I and II clinical trial final result
    Jonny, Jonny
    Putranto, Terawan Agus
    Yana, Martina Lily
    Sitepu, Enda Cindylosa
    Irfon, Raoulian
    Ramadhani, Bunga Pinandhita
    Sofro, Muchlis Achsan Udji
    Nency, Yetty Movieta
    Lestari, Endang Sri
    Triwardhani, Ria
    Mujahidah, Retty Karisma
    Sari, Retty Karisma
    Soetojo, Nur Alaydrus
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] ONE-YEAR FOLLOW-UP OF VACCINE THERAPY IN HIV-INFECTED IMMUNE-DEFICIENT INDIVIDUALS - A NEW STRATEGY
    ZAGURY, D
    BERNARD, J
    HALBREICH, A
    BIZZINI, B
    CARELLI, C
    ACHOUR, A
    DEFER, MC
    BERTHO, JM
    LANNEVAL, K
    ZAGURY, JF
    SALAUN, JJ
    LURHUMA, Z
    MBAYO, K
    ABOUDPIRAK, E
    LOWELL, G
    LEBON, P
    BURNY, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1992, 5 (07) : 676 - 681
  • [28] Distribution of rotavirus genotypes after vaccine introduction in the Triangulo Mineiro region of Brazil: 4-Year follow-up study
    Dulgheroff, A. C. B.
    Figueiredo, E. F.
    Moreira, L. P.
    Moreira, K. C.
    Moura, L. M. S.
    Gouvea, V. S.
    Domingues, A. L. S.
    JOURNAL OF CLINICAL VIROLOGY, 2012, 55 (01) : 67 - 71
  • [29] The effect of immunization with inactivated hepatitis A vaccine on the clinical course of HIV-1 infection: 1-year follow-up
    Bodsworth, NJ
    Neilsen, GA
    Donovan, B
    AIDS, 1997, 11 (06) : 747 - 749
  • [30] Breast cancer patients and survivors: perceived safety and understanding about the COVID-19 vaccine and impact of the pandemic on treatment and follow-up
    Kim, Soo Y.
    Lovo, Stacey
    Sachdeva, Rohit
    DISCOVER PUBLIC HEALTH, 2025, 22 (01)
12345